Hydroxyzine HCL 25 MG tablet 100S
Ended Awarded
- Contract number
- SPE2D326F374L
- Awardee
-
Marlex Pharmaceuticals Inc. UEI VSSNJEFMPLB3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $2,060
Award facts
- Contract value 100% obligated
- $2,059.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- New Castle, DE 19720, USA
Award details come from SAM.gov/FPDS.
About this award
Medical Supply Chain, a Defense-designated funding agency, issued a firm-fixed-price delivery order to Marlex Pharmaceuticals Inc. on August 12, 2026, with a ceiling value of $2,059.75. Marlex is a minority-owned, Subcontinent Asian American-owned small disadvantaged business. The order was issued with no set-aside. It procures 100-count hydroxyzine HCl 25 mg tablets for delivery to New Castle, Delaware 19720. Performance runs from award through August 13, 2026.
Quick answers
Who was awarded contract SPE2D326F374L?
SPE2D326F374L was awarded to Marlex Pharmaceuticals Inc. by Medical Supply Chain (Troop Support) on August 12, 2026.
How much is contract SPE2D326F374L worth?
The government has obligated $2,060 on SPE2D326F374L.
Is contract SPE2D326F374L an order under another contract?
Yes. SPE2D326F374L is a delivery order under SPE2D020D0008, an indefinite delivery contract.
Was contract SPE2D326F374L competed?
The extent of competition for SPE2D326F374L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award